Position in ZYME
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,748,483
-$736,397 QoQ
Shares Held
189,636
-9.0% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ZYME Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,292,861,286 across 390 Biotechnology names. ZYME ranks #30 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in ZYME
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,748,483 | 189,636 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,484,880 | 208,313 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,016,908 | 176,634 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,088,670 | 166,428 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,194,679 | 100,309 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,401,807 | 164,058 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,226,494 | 177,410 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,447,320 | 170,073 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,510,985 | 238,687 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,475,374 | 238,246 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,214,933 | 191,630 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,783,217 | 206,391 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $767,197 | 84,867 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $796,476 | 101,333 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||